We are live on
!
Find out more
PPCM
Pillar Pacific Capital Management Portfolio holdings
AUM
$1.29B
1-Year Est. Return
80.18%
This Fund
S&P 500
This Quarter
Est. Return
+1.74%
1 Year Est. Return
+80.18%
3 Year Est. Return
+84.96%
5 Year Est. Return
+177.6%
10 Year Est. Return
–
AUM
$546M
AUM Growth
+$13.2M
(+2.5%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
1.89%
Top 10 Holdings %
Top 10 Hldgs %
15.16%
Holding
314
New
14
Increased
112
Reduced
70
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.83M |
| 2 |
Bread Financial
BFH
|
+$2.64M |
| 3 |
IBM
IBM
|
+$882K |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$561K |
| 5 |
Magna International
MGA
|
+$520K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.4M |
| 2 |
NE
Noble Corporation
NE
|
+$712K |
| 3 |
JPMorgan Chase
JPM
|
+$637K |
| 4 |
Phillips 66
PSX
|
+$469K |
| 5 |
KOG
KODIAK OIL & GAS CORP
KOG
|
+$397K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.94% |
| 2 | Industrials | 15.37% |
| 3 | Healthcare | 14.42% |
| 4 | Financials | 13.79% |
| 5 | Consumer Discretionary | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Gilead Sciences
GILD
$161B
| $12.1M | 2.21% |
113,419
+224
| +0.2% | +$21.9K |
|
2
Apple
AAPL
$4.89T
| $8.89M | 1.63% |
353,152
+6,492
| +2% | +$159K |
|
3
Biogen
BIIB
$29.9B
| $8.35M | 1.53% |
25,226
-218
| -0.9% | -$71.9K |
|
4
Alphabet (Google) Class C
GOOG
$3.9T
| $8.29M | 1.52% |
285,121
+1,324
| +0.5% | +$38.3K |
|
|
CELG
5
DELISTED
Celgene Corp
CELG
| $8.2M | 1.5% |
86,470
+635
| +0.7% | +$57.3K |
|
6
Union Pacific
UNP
$182B
| $8.12M | 1.49% |
74,925
-191
| -0.3% | -$19.8K |
|
7
Microsoft
MSFT
$2.84T
| $7.74M | 1.42% |
166,872
+1,503
| +0.9% | +$67K |
|
8
Walt Disney
DIS
$165B
| $7.18M | 1.31% |
80,631
-16
| -0% | -$1.41K |
|
9
Intel
INTC
$464B
| $7.08M | 1.3% |
203,382
+4,325
| +2% | +$146K |
|
10
Amgen
AMGN
$203B
| $6.9M | 1.26% |
49,128
+530
| +1% | +$69.2K |
|
11
Thermo Fisher Scientific
TMO
$211B
| $6.78M | 1.24% |
55,693
+1,120
| +2% | +$136K |
|
12
Boeing
BA
$165B
| $6.71M | 1.23% |
52,633
+986
| +2% | +$124K |
|
|
13
IBM
IBM
$202B
| $6.69M | 1.23% |
36,876
+4,841
| +15% | +$882K |
|
14
Bank of America
BAC
$435B
| $6.51M | 1.19% |
381,928
+2,795
| +0.7% | +$44.5K |
|
15
Oracle
ORCL
$331B
| $6.35M | 1.16% |
165,897
+5,189
| +3% | +$210K |
|
16
CSX Corp
CSX
$98.6B
| $6.3M | 1.15% |
589,497
-4,245
| -0.7% | -$43.8K |
|
17
Mastercard
MA
$477B
| $6.26M | 1.15% |
84,670
+540
| +0.6% | +$41.1K |
|
18
Halliburton
HAL
$27.9B
| $6.15M | 1.13% |
95,331
+2,791
| +3% | +$191K |
|
19
DuPont de Nemours
DD
$18.6B
| $5.8M | 1.06% |
43,690
+2,592
| +6% | +$346K |
|
20
Chevron
CVX
$388B
| $5.57M | 1.02% |
46,640
-11
| -0% | -$1.4K |
|
|
ESRX
21
DELISTED
Express Scripts Holding Company
ESRX
| $5.54M | 1.01% |
78,462
-1,075
| -1% | -$76.6K |
|
22
Wells Fargo
WFC
$261B
| $5.5M | 1.01% |
106,014
+3,495
| +3% | +$180K |
|
|
RTN
23
DELISTED
Raytheon Company
RTN
| $5.49M | 1.01% |
54,050
+755
| +1% | +$72.3K |
|
24
Citigroup
C
$222B
| $5.4M | 0.99% |
104,299
+2,395
| +2% | +$120K |
|
25
Lowe's Companies
LOW
$116B
| $5.38M | 0.98% |
101,630
+2,590
| +3% | +$131K |
|
Similar funds
AAM
ALSV
TNB
FIB
NAM
SGMP
OP
FBP
Pillar Pacific Capital Management's Q3 2014 Portfolio in Review
As of Q3 2014, Pillar Pacific Capital Management held 314 positions worth $546M, up 2.5% from $533M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Pillar Pacific Capital Management's Q3 2014 filing shows 14 new, 112 increased, 70 reduced and 12 closed positions. Its largest new stake was Proofpoint, Inc.: 7,800 shares worth $290K. The largest sale was Eli Lilly, an estimated $1.4M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Healthcare.
- Pillar Pacific Capital Management's largest Q3 2014 buy was Proofpoint, Inc.: 7,800 shares worth $290K.
- Pillar Pacific Capital Management added most to Allergan plc in Q3 2014, an estimated $2.83M increase.
- Pillar Pacific Capital Management's biggest Q3 2014 reduction was Eli Lilly, cutting an estimated $1.4M.
- Pillar Pacific Capital Management fully exited Phillips 66 in Q3 2014, selling an estimated $469K.
- Pillar Pacific Capital Management's ten largest holdings make up 15% of its $546M portfolio in Q3 2014.
- Pillar Pacific Capital Management opened 14 new positions and closed 12 in Q3 2014.
- Pillar Pacific Capital Management's portfolio value rose 2.5% quarter-over-quarter to $546M.
Based on Pillar Pacific Capital Management's 13F filing for Q3 2014, filed 3 Nov 2014.